Evergreen Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Sell
27,427
-10
-0% -$1.72K 0.09% 200
2026
Q1
$4.63M Sell
27,437
-838
-3% -$143K 0.1% 204
2025
Q4
$4.77M Buy
28,275
+2,646
+10% +$430K 0.11% 191
2025
Q3
$3.7M Hold
25,629
0.09% 207
2025
Q2
$3.24M Sell
25,629
-3,124
-11% -$384K 0.1% 207
2025
Q1
$3.68M Sell
28,753
-2,283
-7% -$310K 0.12% 187
2024
Q4
$4.1M Sell
31,036
-2,699
-8% -$379K 0.13% 171
2024
Q3
$4.91M Sell
33,735
-999
-3% -$145K 0.16% 152
2024
Q2
$4.77M Sell
34,734
-868
-2% -$116K 0.17% 147
2024
Q1
$4.89M Sell
35,602
-26,474
-43% -$3.62M 0.18% 137
2023
Q4
$8.43M Sell
62,076
-4,898
-7% -$598K 0.34% 85
2023
Q3
$8.2M Buy
66,974
+651
+1% +$82.8K 0.36% 82
2023
Q2
$8.42M Buy
66,323
+901
+1% +$117K 0.35% 81
2023
Q1
$8.45M Buy
65,422
+6,789
+12% +$889K 0.38% 77
2022
Q4
$7.7M Buy
58,633
+25,610
+78% +$3.31M 0.36% 81
2022
Q3
$3.86M Buy
33,023
+28,724
+668% +$3.57M 0.2% 135
2022
Q2
$506K Buy
4,299
+236
+6% +$28K 0.03% 330
2022
Q1
$529K Buy
4,063
+487
+14% +$63.4K 0.02% 365
2021
Q4
$546K Buy
+3,576
New +$554K 0.02% 362
2018
Q3
Sell
-3,000
Closed -$329K 399
2018
Q2
$329K Buy
+3,000
New +$321K 0.03% 252

Other funds holding IBB

Evergreen Capital Management's IBB Position: Q2 2026 in Review

Evergreen Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q2 2026, selling an estimated $1.72K and leaving 27,427 shares worth $5.22M. The position accounts for 0.09% of the portfolio, ranked #200.

Evergreen Capital Management first reported a position in IBB in Q2 2018 and has held it in 20 quarters since. The position peaked at $8.45M in Q1 2023. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Evergreen Capital Management held 27,427 shares of iShares Biotechnology ETF worth $5.22M as of Q2 2026.
  • Evergreen Capital Management sold 10 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.72K.
  • iShares Biotechnology ETF made up 0.09% of Evergreen Capital Management's portfolio in Q2 2026, its #200 holding.
  • Evergreen Capital Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 20 quarters since.
  • Evergreen Capital Management's iShares Biotechnology ETF position peaked at $8.45M in Q1 2023.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.